Gut Liver.  2014 Nov;8(6):662-668. 10.5009/gnl13392.

High Expression of Ribonucleotide Reductase Subunit M2 Correlates with Poor Prognosis of Hepatocellular Carcinoma

• Lee B
• Ha SY
• Song DH
• Lee HW
• Cho SY
• Park CK

• KMID: 2070085
• DOI: http://doi.org/10.5009/gnl13392

Abstract

BACKGROUND/AIMS
Ribonucleotide reductase subunit M2 (RRM2) catalyzes the production of deoxynucleotide triphosphates, which are necessary for DNA synthesis. RRM2 has been reported to play an active role in tumor progression, and elevated RRM2 levels have been correlated with poor prognosis for colorectal cancer patients. This study aimed to elucidate the prognostic significance of RRM2 protein expression in hepatocellular carcinoma after surgery.
METHODS
RRM2 protein expression was evaluated using immunohistochemistry in tumor tissues from 259 hepatocellular carcinoma patients who underwent curative hepatectomy.
RESULTS
High RRM2 expression was observed in 210 of 259 patients (81.1%) with hepatocellular carcinomas. High RRM2 expression was significantly associated with viral etiology (p=0.035) and liver cirrhosis (p=0.036). High RRM2 expression was correlated with early recurrence (p=0.004) but not with late recurrence (p=0.144). Logistic regression analysis revealed that high RRM2 expression (p=0.040) and intrahepatic metastasis (p<0.001) were independent predictors of early recurrence. High RRM2 expression unfavorably influenced both shorter recurrence-free survival (p=0.011) and shorter disease-specific survival (p=0.002) and was an independent predictor of shorter disease-specific survival (p=0.008).
CONCLUSIONS
High RRM2 protein expression might be a useful marker for predicting early recurrence and may be a marker for poor prognosis of hepatocellular carcinoma after curative hepatectomy.

Keyword

Ribonucleotide reductase subunit M2; Hepatocellular carcinoma; Survival

MeSH Terms

Adolescent
Adult
Aged
Carcinoma, Hepatocellular/*metabolism/surgery
Disease-Free Survival
Female
Hepatectomy
Humans
Immunohistochemistry
Liver Neoplasms/*metabolism/surgery
Logistic Models
Male
Middle Aged
Neoplasm Recurrence, Local/*metabolism
Prognosis
Ribonucleoside Diphosphate Reductase/*metabolism
Tumor Markers, Biological/*metabolism
Young Adult
Tumor Markers, Biological
Ribonucleoside Diphosphate Reductase